Cellebrite (CLBT): CEO Shift and Guidance Cuts Contrast With Surging AI and FedRAMP Gains
On August 13, Cellebrite (NASDAQ:CLBT) named a new chief executive and trimmed its full-year outlook on the same morning.
Cellebrite Di Ltd. (CLBT)
Market is closed
Sector: Services-Prepackaged Software
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Voss Capital Travis Cocke | 11,441,874 | $167,051,360 | +19% | 7.76% |
| 2. | Pertento Partners Ian Trundle | 8,004,867 | $116,871,058 | +21% | 6.3% |
| 3. | Nine Ten Partners Brian Bares, Russell Mollen, And James Bradshaw | 4,126,808 | $60,251,000 | +20% | 18.75% |
| 4. | Renaissance Technologies Jim Simons | 2,150,239 | $31,393,489 | -25% | 0.04% |
| 5. | Portolan Capital Management George Mccabe | 1,932,514 | $28,214,704 | -12% | 1.06% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.29 | 25,299 | $285,711.73 | 765,249 | 2026-08-25 | Filing | |
| $11.36 | 4,323 | $49,111.44 | 135,281 | 2026-08-24 | Filing | |
| $11.24 | 12,562 | $141,216.98 | 427,128 | 2026-08-21 | Filing | |
| $11.24 | 2,198 | $24,709.04 | 139,604 | 2026-08-21 | Filing | |
| $15.39 | 139,713 | $2,149,638.19 | 790,548 | 2026-08-12 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,360 | $71,614 | 0% | |
| 2. | 5,833 | $65,682 | 0.02% | |
| 3. | 2,980 | $33,555 | 0% | |
| 4. | 150 | $1,689 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Cellebrite’s (CLBT) Compounding Track Record Demands Enterprise Software Re-Rating
Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now?
Is CLBT a good stock to buy? We came across a bullish thesis on Cellebrite DI Ltd. on InfoArb Sheets’s Substack. In this article, we will summarize the bulls’ thesis on CLBT.
10 Stocks Under $20 That Will Explode
In this piece, we discuss the 10 Stocks Under $20 That Will Explode. Global markets are navigating uncertain terrain right now.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q1 2026 Earnings Call Transcript
Cellebrite DI Ltd. (NASDAQ:CLBT) Q1 2026 Earnings Call Transcript May 14, 2026Cellebrite DI Ltd. beats earnings expectations. Reported EPS is $0.12, expectations were $0.11.
Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now?
Is CLBT a good stock to buy? We came across a bullish thesis on Cellebrite DI Ltd. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on CLBT.
10 Best Cybersecurity Stocks to Invest in According to Analysts
In this article, we will look at some of the best names in the cybersecurity space that currently offer attractive upside for investors.
10 Tech Stocks to Sell Right Now According to Cathie Wood
In this article, we explore the 10 Tech Stocks to Sell Right Now According to Cathie Wood.
10 Best NASDAQ Stocks Under $30 to Buy
In this article, we will discuss the 10 Best NASDAQ Stocks Under $30 to Buy.
Artisan Small Cap Fund Picked Cellebrite (CLBT) Following New Product Cycle Analysis
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here.
Hedge Fund Resource Center